文献速递生殖医学

利用人群系谱数据描述生育力低下男性的家族性癌症风险模式

Describing patterns of familial cancer risk in subfertile men using population pedigree data.
PubMed 文献 · Hum Reprod · 2024-01-01

回顾性队列研究将786名无精子症或严重少精子症男性与5674名可生育对照按5:1匹配,并追溯至三级亲属(共337754人),分析1966-2017年犹他州癌症登记数据。无精子症家族5种癌症风险显著升高,严重少精子症家族3种升高、1种降低;分别识别出13个和12个家族性多癌模式聚类,部分聚类年轻发病风险增高。

要点

  • 无精子症家族骨关节癌HR=2.56、软组织癌HR=1.56、子宫癌HR=1.27、霍奇金淋巴瘤HR=1.60、甲状腺癌HR=1.54。
  • 严重少精子症家族结肠癌HR=1.16、骨关节癌HR=2.43、睾丸癌HR=2.34,食管癌HR=0.39。
  • 两队列分别识别13个和12个家族性多癌聚类,部分聚类青少年及儿童期诊断几率增高。

核心结论

  • 无精子症与严重少精子症队列呈现不同的家族性多癌风险模式,提示家族性癌症风险在生育力低下类型之间及类型内部存在异质性。

研究设计与样本

  • 回顾性队列研究,生育力低下男性N=786与可生育人群对照N=5674按年龄和性别5:1匹配,追溯至三级亲属共N=337754人,研究期间1966-2017年。
  • 无精子症(0×10^6/mL)和严重少精子症(<1.5×10^6/mL)男性来自SHARE队列,对照及亲属来自犹他州人口数据库(UPDB),癌症诊断来自犹他州癌症登记。
  • 纳入随访≥1年且家族中≥10名成员的家庭:无精子症N=426个家庭、21361人;少精子症N=360个家庭、18818人。
  • 基于34种癌症表型的标准化发病比进行无监督聚类识别家族性多癌模式,无精子症与严重少精子症家庭分别评估。

主要发现

  • 与对照家庭相比,无精子症队列5种癌症风险显著升高:骨和关节癌HR=2.56(95%CI=1.48-4.42)、软组织癌HR=1.56(95%CI=1.01-2.39)、子宫癌HR=1.27(95%CI=1.03-1.56)、霍奇金淋巴瘤HR=1.60(95%CI=1.07-2.39)、甲状腺癌HR=1.54(95%CI=1.21-1.97)。
  • 严重少精子症家庭3种癌症风险升高:结肠癌HR=1.16(95%CI=1.01-1.32)、骨和关节癌HR=2.43(95%CI=1.30-4.54)、睾丸癌HR=2.34(95%CI=1.60-3.42),食管癌风险显著降低HR=0.39(95%CI=0.16-0.97)。
  • 无精子症家庭识别出13个家族性多癌聚类,其中66%家庭显示人群水平癌症风险,其余12个聚类显示2-7种癌症风险升高。
  • 无精子症队列中6个聚类青少年和年轻成人(AYA)诊断几率增高(OR=1.96-2.88),2个聚类儿童期癌症诊断几率增高(OR=3.64-12.63)。
  • 严重少精子症队列识别出12个家族性多癌聚类,均显示1-3种癌症风险升高;5个聚类年轻发病几率增高,其中3个AYA诊断OR=2.19-2.78,另2个儿童期诊断OR=3.84-9.32。

临床怎么用

  • 作者认为,描述具有相似癌症风险模式的家族为聚焦基因发现和环境风险因素研究提供了提高同质性的新途径。
  • 作者认为,此类发现将带来更准确的风险预测并改善对患者及其家庭的咨询。

局限性

  • 可生育男性样本无精液检测数据。
  • 缺乏合并症或生活方式危险因素信息,如吸烟状态、BMI或环境暴露。
  • 所有纳入的生育力低下男性均在生育门诊接受评估,可能代表具有就医社会经济条件的人群子集。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Can we simultaneously assess risk for multiple cancers to identify familial multicancer patterns in families of azoospermic and severely oligozoospermic men? SUMMARY ANSWER: Distinct familial cancer patterns were observed in the azoospermia and severe oligozoospermia cohorts, suggesting heterogeneity in familial cancer risk by both type of subfertility and within subfertility type. WHAT IS KNOWN ALREADY: Subfertile men and their relatives show increased risk for certain cancers including testicular, thyroid, and pediatric. STUDY DESIGN, SIZE, DURATION: A retrospective cohort of subfertile men (N = 786) was identified and matched to fertile population controls (N = 5674). Family members out to third-degree relatives were identified for both subfertile men and fertile population controls (N = 337 754). The study period was 1966-2017. Individuals were censored at death or loss to follow-up, loss to follow-up occurred if they left Utah during the study period. PARTICIPANTS/MATERIALS, SETTING, METHODS: Azoospermic (0 × 106/mL) and severely oligozoospermic (<1.5 × 106/mL) men were identified in the Subfertility Health and Assisted Reproduction and the Environment cohort (SHARE). Subfertile men were age- and sex-matched 5:1 to fertile population controls and family members out to third-degree relatives were identified using the Utah Population Database (UPDB). Cancer diagnoses were identified through the Utah Cancer Registry. Families containing ≥10 members with ≥1 year of follow-up 1966-2017 were included (azoospermic: N = 426 families, 21 361 individuals; oligozoospermic: N = 360 families, 18 818 individuals). Unsupervised clustering based on standardized incidence ratios for 34 cancer phenotypes in the families was used to identify familial multicancer patterns; azoospermia and severe oligospermia families were assessed separately. MAIN RESULTS AND THE ROLE OF CHANCE: Compared to control families, significant increases in cancer risks were observed in the azoospermia cohort for five cancer types: bone and joint cancers hazard ratio (HR) = 2.56 (95% CI = 1.48-4.42), soft tissue cancers HR = 1.56 (95% CI = 1.01-2.39), uterine cancers HR = 1.27 (95% CI = 1.03-1.56), Hodgkin lymphomas HR = 1.60 (95% CI = 1.07-2.39), and thyroid cancer HR = 1.54 (95% CI = 1.21-1.97). Among severe oligozoospermia families, increased risk was seen for three cancer types: colon cancer HR = 1.16 (95% CI = 1.01-1.32), bone and joint cancers HR = 2.43 (95% CI = 1.30-4.54), and testis cancer HR = 2.34 (95% CI = 1.60-3.42) along with a significant decrease in esophageal cancer risk HR = 0.39 (95% CI = 0.16-0.97). Thirteen clusters of familial multicancer patterns were identified in families of azoospermic men, 66% of families in the azoospermia cohort showed population-level cancer risks, however, the remaining 12 clusters showed elevated risk for 2-7 cancer types. Several of the clusters with elevated cancer risks also showed increased odds of cancer diagnoses at young ages with six clusters showing increased odds of adolescent and young adult (AYA) diagnosis [odds ratio (OR) = 1.96-2.88] and two clusters showing increased odds of pediatric cancer diagnosis (OR = 3.64-12.63). Within the severe oligozoospermia cohort, 12 distinct familial multicancer clusters were identified. All 12 clusters showed elevated risk for 1-3 cancer types. An increase in odds of cancer diagnoses at young ages was also seen in five of the severe oligozoospermia familial multicancer clusters, three clusters showed increased odds of AYA diagnosis (OR = 2.19-2.78) with an additional two clusters showing increased odds of a pediatric diagnosis (OR = 3.84-9.32). LIMITATIONS, REASONS FOR CAUTION: Although this study has many strengths, including population data for family structure, cancer diagnoses and subfertility, there are limitations. First, semen measures are not available for the sample of fertile men. Second, there is no information on medical comorbidities or lifestyle risk factors such as smoking status, BMI, or environmental exposures. Third, all of the subfertile men included in this study were seen at a fertility clinic for evaluation. These men were therefore a subset of the overall population experiencing fertility problems and likely represent those with the socioeconomic means for evaluation by a physician. WIDER IMPLICATIONS OF THE FINDINGS: This analysis leveraged unique population-level data resources, SHARE and the UPDB, to describe novel multicancer clusters among the families of azoospermic and severely oligozoospermic men. Distinct overall multicancer risk and familial multicancer patterns were observed in the azoospermia and severe oligozoospermia cohorts, suggesting heterogeneity in cancer risk by type of subfertility and within subfertility type. Describing families with similar cancer risk patterns provides a new avenue to increase homogeneity for focused gene discovery and environmental risk factor studies. Such discoveries will lead to more accurate risk predictions and improved counseling for patients and their families. STUDY FUNDING/COMPETING INTEREST(S): This work was funded by GEMS: Genomic approach to connecting Elevated germline Mutation rates with male infertility and Somatic health (Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD): R01 HD106112). The authors have no conflicts of interest relevant to this work. TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Ramsay JM, Madsen MJ, Horns JJ, et al. Describing patterns of familial cancer risk in subfertile men using population pedigree data. Hum Reprod. 2024. PMID: 38383051. doi:10.1093/humrep/dead270

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。